MERRIMACK PHARMACEUTICALS INC Total Assets
MERRIMACK PHARMACEUTICALS INC had Total Assets of $244.32 million as of 2024-03-31, per its 10-Q filed 2024-05-15.
Discontinued › Balance Sheet › Assets
us-gaap:Assets · last filed 2024-05-15
- 2024-03-31: Assets $244.32M.
- 2023-12-31: Assets $19.19M.
- 2023-09-30: Assets $19.30M.
- 2023-06-30: Assets $19.45M.
| Period end | Assets | Assets as first filed |
|---|---|---|
| 2024-03-31 | $244.32M 10-Q · filed 2024-05-15 | |
| 2023-12-31 | $19.19M 10-Q · filed 2024-05-15 | |
| 2023-09-30 | $19.30M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $19.45M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $19.64M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $19.84M 10-K · filed 2024-03-07 | |
| 2022-09-30 | $13.64M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $14.05M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $14.64M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $14.75M 10-K · filed 2023-03-09 | |
| 2021-09-30 | $15.30M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $15.86M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $16.44M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $16.78M 10-K · filed 2022-03-09 | |
| 2020-09-30 | $18.96M 10-Q · filed 2020-11-04 | |
| 2020-06-30 | $19.68M 10-Q · filed 2020-08-07 | |
| 2020-03-31 | $21.34M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $20.08M 10-K · filed 2021-03-10 | |
| 2019-09-30 | $24.84M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $45.04M 10-Q · filed 2019-07-17 | |
| 2019-03-31 | $74.35M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $88.54M 10-K · filed 2020-03-12 | |
| 2018-09-30 | $103.92M 10-Q · filed 2018-11-07 | |
| 2018-06-30 | $80.23M 10-Q · filed 2018-08-07 | |
| 2018-03-31 | $97.50M 10-Q · filed 2018-05-08 | |
| 2017-12-31 | $117.33M 10-K · filed 2019-03-06 | |
| 2017-09-30 | $197.85M 10-Q · filed 2017-11-08 | |
| 2017-06-30 | $213.45M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $68.64M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $81.48M 10-K · filed 2018-03-12 | |
| 2016-09-30 | $118.41M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $150.02M 10-Q · filed 2016-08-04 | |
| 2016-03-31 | $192.93M 10-Q · filed 2016-05-02 | |
| 2015-12-31 | $234.88M 8-K · filed 2017-12-15 | |
| 2015-09-30 | $102.68M 10-Q · filed 2015-11-09 | |
| 2015-06-30 | $105.04M 10-Q · filed 2015-08-10 | |
| 2015-03-31 | $127.02M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $158.51M 10-K · filed 2016-02-26 | $158.66M 10-K · filed 2015-02-27 |
| 2014-09-30 | $188.60M 10-Q · filed 2014-11-10 | |
| 2014-06-30 | $129.81M 10-Q · filed 2014-08-11 | |
| 2014-03-31 | $164.98M 10-Q · filed 2014-05-06 | |
| 2013-12-31 | $192.42M 10-K · filed 2015-02-27 | |
| 2013-09-30 | $224.24M 10-Q · filed 2013-11-08 | |
| 2013-06-30 | $107.32M 10-Q · filed 2013-08-08 | |
| 2013-03-31 | $127.32M 10-Q · filed 2013-05-13 | |
| 2012-12-31 | $148.97M 10-K · filed 2014-03-04 | |
| 2012-09-30 | $123.21M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $138.71M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $64.45M 10-Q · filed 2012-05-15 | |
| 2011-12-31 | $85.30M 10-K · filed 2013-03-20 |